Pacific Palisades, CA, United States of America

Michele Tagliati


 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michele Tagliati: Innovator in Neurodegenerative Treatment

Introduction

Michele Tagliati is a prominent inventor based in Pacific Palisades, CA (US). He has made significant contributions to the field of neurodegenerative conditions, holding a total of 4 patents. His work focuses on innovative methods for treating and diagnosing conditions such as Alzheimer's disease and idiopathic Parkinson's disease.

Latest Patents

One of Michele Tagliati's latest patents involves adrenoceptor antagonists for the prevention and treatment of neurodegenerative conditions. This patent outlines methods for treating and preventing various neurodegenerative conditions, including Alzheimer's disease and idiopathic Parkinson's disease, by utilizing adrenoceptor antagonists. The patent specifies that adrenoceptor antagonists, such as β-blockers including acebutolol, betaxolol, bisopropolol, bopindolol, carvedilol, metoprolol, oxprenolol, propranolol, and timolol, can be effective in these treatments. Another significant patent focuses on activation map-based individualized planning for deep brain stimulation. This patent describes methods and apparatus for planning and controlling neuro-modulation of a distributed multi-region network in the brain, selecting optimal locations for deep brain stimulation electrodes based on pre-implantation images and probabilistic activation models.

Career Highlights

Michele Tagliati has worked with esteemed institutions such as Case Western Reserve University and Cedars-Sinai Medical Center. His experience in these organizations has contributed to his expertise in neurodegenerative research and treatment.

Collaborations

Michele has collaborated with notable colleagues, including Cameron C McIntyre and Patricio Riva-Posse. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Michele Tagliati is a distinguished inventor whose work in neurodegenerative treatment has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…